AGEN on XNAS, Health Care, Agenus Inc., job postings
Measures activity, not value. Not investment advice.
Profit of $30.8M on revenue up 25% while short interest reached 17% of shares.
GoodInstitutional holders rose to 123 from 103 last quarter
GoodShares up 92% over six months and 39% over twelve
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
Industry
Biological products, (no diagnostic substances) (Health Care)
expected around 15 Mar 2027 (an estimate: a year ago it reported on 16 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $31.5M, net income $2.7M.
31 Dec 2021RevenueNet incomeNet losstallest bar $83.8M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$31.5M
$2.7M
30 Jun 2026
$34.5M
-$567K
31 Mar 2026
$33.7M
$39.2M
31 Dec 2025
$34.2M
-$10.6M
30 Sep 2025
$30.2M
$63.9M
30 Jun 2025
$25.7M
-$30.0M
31 Mar 2025
$24.1M
-$26.4M
31 Dec 2024
$26.8M
-$46.8M
30 Sep 2024
$25.1M
-$67.2M
30 Jun 2024
$23.5M
-$54.8M
31 Mar 2024
$28.0M
-$63.5M
31 Dec 2023
$83.8M
-$48.6M
30 Sep 2023
$24.3M
-$64.5M
30 Jun 2023
$25.3M
-$73.4M
31 Mar 2023
$22.9M
-$70.9M
31 Dec 2022
$28.4M
-$74.1M
30 Sep 2022
$22.8M
-$56.7M
30 Jun 2022
$20.9M
-$49.2M
31 Mar 2022
$25.9M
-$50.6M
31 Dec 2021
$20.3M
-$67.6M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$133.9M
$106.8M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+25%
+8.2%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$30.8M
-$39.3M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
–
–
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
100%
98.9%
70.4%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
38.9%
-56.6%
-98.6%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
23.0%
-36.8%
-47.8%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
–
-58.2%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$86.9M
$3.5M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$35.1M
$34.2M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$51.8M (net cash)
$30.7M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
0.0
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
–
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
8.8
21.6
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
2.0
8.0
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
1.6
6.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
–
2.0
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+19%
123 13F filers vs 103
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
58%
26.3M shares held by 13F filers (30 Sep 2026) of 45.2M outstanding (3 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
17%
7.6M shares sold short (30 Oct 2026) of 45.2M outstanding (3 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
10.7
7.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+8.5%
7.0M shares sold short in the report before, 7.6M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
59%
59% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 54%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+4.1%
$31.5M vs $30.2M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
3
3 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
1.5×
3 articles in the last 7 days; its usual week has 2.
Price $5.97 on 20 Nov 2026, +39% over 12 months (12-month range $2.77 to $9.93)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $0).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months, 0% on the 12 months before.Revenue per quarter. Revenue $31.5M in the latest quarter, +4.1% on a year earlier.Capital spending per quarter. Capital spending $0 in the latest quarter.Institutional holders (13F filers). 123 13F filers reported holding it in the latest 13F quarter, +54% on a year earlier.Federal obligations. Federal obligations: $0 published in the last 12 months, -100% on the 12 months before.Lobbying spend. Lobbying spend: $0 published in the last 12 months.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.
Quarter ended 31 Dec 2021: $20.3M, -35% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $25.9M, +121% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $20.9M, +95% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $22.8M, -91% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $28.4M, +40% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $22.9M, -12% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $25.3M, +21% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $24.3M, +6.8% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $83.8M, +195% on a year earlier; public on 15 Mar 2024
Quarter ended 31 Mar 2024: $28.0M, +22% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $23.5M, -7.1% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $25.1M, +3.3% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $26.8M, -68% on a year earlier; public on 18 Mar 2025
Quarter ended 31 Mar 2025: $24.1M, -14% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $25.7M, +9.3% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $30.2M, +20% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $34.2M, +27% on a year earlier; public on 17 Mar 2026
Quarter ended 31 Mar 2026: $33.7M, +40% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $34.5M, +34% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $31.5M, +4.1% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $9.0M, +975% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $4.5M, +2218% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $18.5M, +713% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $15.7M; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $14.3M, +60% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $1.8M, -59% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $4.4M, -76% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $3.5M, -78% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $223K, -98% on a year earlier; public on 15 Mar 2024
Quarter ended 31 Mar 2024: $35K, -98% on a year earlier; public on 8 May 2024
Quarter ended 30 Sep 2024: $7K, -100% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $73K, -67% on a year earlier; public on 18 Mar 2025
Quarter ended 31 Mar 2025: $5K, -86% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $1K; public on 12 Aug 2025
Quarter ended 31 Mar 2026: $0, -100% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $0, -100% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $0; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 160; public on 14 Feb 2022
31 Mar 2022 report: 165; public on 16 May 2022
30 Jun 2022 report: 145; public on 15 Aug 2022
30 Sep 2022 report: 154; public on 14 Nov 2022
31 Dec 2022 report: 146; public on 14 Feb 2023
31 Mar 2023 report: 150; public on 15 May 2023
30 Jun 2023 report: 149; public on 14 Aug 2023
30 Sep 2023 report: 146; public on 14 Nov 2023
31 Dec 2023 report: 156; public on 14 Feb 2024
31 Mar 2024 report: 123; public on 15 May 2024
30 Jun 2024 report: 83; public on 14 Aug 2024
30 Sep 2024 report: 94; public on 14 Nov 2024
31 Dec 2024 report: 84; public on 14 Feb 2025
31 Mar 2025 report: 82; public on 15 May 2025
30 Jun 2025 report: 87; public on 14 Aug 2025
30 Sep 2025 report: 80; public on 14 Nov 2025
31 Dec 2025 report: 90; public on 17 Feb 2026
31 Mar 2026 report: 87; public on 15 May 2026
30 Jun 2026 report: 103; public on 14 Aug 2026
30 Sep 2026 report: 123; public on 16 Nov 2026
Federal obligations
Month from 1 Jun 2025: $306K published
Lobbying spend
Quarter from 1 Oct 2023: $30K published
Quarter from 1 Jan 2024: $45K published
Quarter from 1 Apr 2024: $30K published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $325K (15 Feb 2024), 25× its normal reading; higher than 77% of its own history.
Reported lobbying spend: $30K in Q1 2024, $45K in Q4 2023. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Mar 2024
Ended
Tides Group, LLCfor Agenus Inc.
Issues related to colorectal cancer immunotherapy.MED, Health issues
Two or more unrelated kinds of records unusual within 30 days
16 Oct 2023confirmed
Confirmed across sources Lobbying and Short interest and volume
Agenus(AGEN): lobbying on a new issue, while it had 44.1M shares sold short in the 15 Dec 2023 report, 2.3× the same report last year. Two unrelated kinds of activity within 133 days.
Short interest and volume: Short interest spike, became public on 13 Sep 2023
Short interest and volume: Short interest spike, became public on 27 Sep 2023
Lobbying: Lobbying on a new issue, became public on 16 Oct 2023
Short interest and volume: Short interest spike, became public on 12 Oct 2023
Short interest and volume: Short interest spike, became public on 25 Oct 2023
Short interest and volume: Short interest spike, became public on 10 Nov 2023
Short interest and volume: Short interest spike, became public on 28 Nov 2023
Short interest and volume: Short interest spike, became public on 12 Dec 2023
Short interest and volume: Short interest spike, became public on 28 Dec 2023
Short interest and volume: Short interest spike, became public on 11 Jan 2024
Short interest and volume: Short interest spike, became public on 25 Jan 2024
The 15 Dec 2023 report against the 24 reports before it.
this reportearliernormal: 20.9MSee the evidence (11 changes)
Short interest and volume: Short interest spike became public on 13 Sep 2023
Agenus had 29.3M shares sold short in the 31 Aug 2023 report, 1.7× the same report last year.
This period
29.3M (the 31 Aug 2023 report)
Normal report (median of 24 earlier)
19.7M
Typical spread (median absolute deviation)
801K
How far from its usual level
+4.9
Same report last year
16.9M
History used
2,071 days
the 31 Aug 2023 report24 earlier reportsnormal: 19.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 27 Sep 2023
Agenus had 29.3M shares sold short in the 15 Sep 2023 report, 1.8× the same report last year.
This period
29.3M (the 15 Sep 2023 report)
Normal report (median of 24 earlier)
20.0M
Typical spread (median absolute deviation)
878K
How far from its usual level
+4.6
Same report last year
16.1M
History used
2,086 days
the 15 Sep 2023 report24 earlier reportsnormal: 20.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Lobbying: Lobbying on a new issue became public on 16 Oct 2023
Agenus lobbying on a new issue.
New
['HCR']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12617734
Short interest and volume: Short interest spike became public on 12 Oct 2023
Agenus had 28.1M shares sold short in the 29 Sep 2023 report, 1.7× the same report last year.
This period
28.1M (the 29 Sep 2023 report)
Normal report (median of 24 earlier)
20.0M
Typical spread (median absolute deviation)
929K
How far from its usual level
+4.0
Same report last year
16.9M
History used
2,100 days
the 29 Sep 2023 report24 earlier reportsnormal: 20.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Oct 2023
Agenus had 30.4M shares sold short in the 13 Oct 2023 report, 1.6× the same report last year.
This period
30.4M (the 13 Oct 2023 report)
Normal report (median of 24 earlier)
20.2M
Typical spread (median absolute deviation)
980K
How far from its usual level
+5.1
Same report last year
18.6M
History used
2,114 days
the 13 Oct 2023 report24 earlier reportsnormal: 20.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Nov 2023
Agenus had 34.2M shares sold short in the 31 Oct 2023 report, 1.8× the same report last year.
This period
34.2M (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
20.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+6.7
Same report last year
19.0M
History used
2,132 days
the 31 Oct 2023 report24 earlier reportsnormal: 20.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 28 Nov 2023
Agenus had 45.4M shares sold short in the 15 Nov 2023 report, 2.0× the same report last year.
This period
45.4M (the 15 Nov 2023 report)
Normal report (median of 24 earlier)
20.6M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+12.0
Same report last year
22.5M
History used
2,147 days
the 15 Nov 2023 report24 earlier reportsnormal: 20.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Dec 2023
Agenus had 43.1M shares sold short in the 30 Nov 2023 report, 2.2× the same report last year.
This period
43.1M (the 30 Nov 2023 report)
Normal report (median of 24 earlier)
20.6M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+10.9
Same report last year
19.9M
History used
2,162 days
the 30 Nov 2023 report24 earlier reportsnormal: 20.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 28 Dec 2023
Agenus had 44.1M shares sold short in the 15 Dec 2023 report, 2.3× the same report last year.
This period
44.1M (the 15 Dec 2023 report)
Normal report (median of 24 earlier)
20.9M
Typical spread (median absolute deviation)
1.6M
How far from its usual level
+9.6
Same report last year
19.0M
History used
2,177 days
the 15 Dec 2023 report24 earlier reportsnormal: 20.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Jan 2024
Agenus had 39.7M shares sold short in the 29 Dec 2023 report, 2.0× the same report last year.
This period
39.7M (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
21.7M
Typical spread (median absolute deviation)
2.3M
How far from its usual level
+5.3
Same report last year
19.5M
History used
2,191 days
the 29 Dec 2023 report24 earlier reportsnormal: 21.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Jan 2024
Agenus had 41.9M shares sold short in the 12 Jan 2024 report, 2.1× the same report last year.
This period
41.9M (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
23.0M
Typical spread (median absolute deviation)
3.6M
How far from its usual level
+3.5
Same report last year
20.3M
History used
2,205 days
the 12 Jan 2024 report24 earlier reportsnormal: 23.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
16 Nov 2021confirmed
Confirmed across sources Institutional holdings and Filings + Financials
Agenus(AGEN): saw 39 13F filers open a new position in the quarter ended 30 Sep 2021, 1.9× the same quarter last year, while it reported revenue of $253.0M for the quarter ended 30 Sep 2021, 17× the same quarter last year. Two unrelated kinds of activity on the same day.
Institutional holdings: Many funds opening a new position, became public on 15 Nov 2021
Financials: Quarterly revenue change, became public on 16 Nov 2021
The quarter ended 30 Sep 2021 against the 8 quarters before it.
this quarterearliernormal: 19See the evidence (2 changes)
Institutional holdings: Many funds opening a new position became public on 15 Nov 2021
Agenus saw 39 13F filers open a new position in the quarter ended 30 Sep 2021, 1.9× the same quarter last year.
This period
39 (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
19
Typical spread (median absolute deviation)
3.5
How far from its usual level
+3.9
Same quarter last year
20
History used
2,922 days
the quarter ended 30 Sep 20218 earlier quartersnormal: 19
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Financials: Quarterly revenue change became public on 16 Nov 2021
Agenus reported revenue of $253.0M for the quarter ended 30 Sep 2021, 17× the same quarter last year.
This period
$253.0M (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$17.5M
Typical spread (median absolute deviation)
$6.3M
How far from its usual level
+25.2
Same quarter last year
$14.8M
History used
4,110 days
the quarter ended 30 Sep 20218 earlier quartersnormal: $17.5M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
had 4.1M shares sold short in the 15 May 2025 report, 1.3× the same report last year.
Same report last year: 3.1M; its normal report is 2.9M.
See the evidence
This period
4.1M (the 15 May 2025 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
209K
How far from its usual level
+3.7
Same report last year
3.1M
History used
2,694 days
the 15 May 2025 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.1M shares sold short in the 30 Apr 2025 report, 1.3× the same report last year.
Same report last year: 3.2M; its normal report is 2.9M.
See the evidence
This period
4.1M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
209K
How far from its usual level
+3.7
Same report last year
3.2M
History used
2,679 days
the 30 Apr 2025 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.1M shares sold short in the 15 Apr 2025 report, 1.6× the same report last year.
Same report last year: 2.6M; its normal report is 2.9M.
See the evidence
This period
4.1M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+3.5
Same report last year
2.6M
History used
2,664 days
the 15 Apr 2025 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
reported revenue of $83.8M for the quarter ended 31 Dec 2023, 3.0× the same quarter last year.
Same quarter last year: $28.4M; its normal quarter is $23.6M.
See the evidence
This period
$83.8M (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$23.6M
Typical spread (median absolute deviation)
$2.0M
How far from its usual level
+20.2
Same quarter last year
$28.4M
History used
4,932 days
the quarter ended 31 Dec 20238 earlier quartersnormal: $23.6M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
had 41.9M shares sold short in the 12 Jan 2024 report, 2.1× the same report last year.
Same report last year: 20.3M; its normal report is 23.0M.
See the evidence
This period
41.9M (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
23.0M
Typical spread (median absolute deviation)
3.6M
How far from its usual level
+3.5
Same report last year
20.3M
History used
2,205 days
the 12 Jan 2024 report24 earlier reportsnormal: 23.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 39.7M shares sold short in the 29 Dec 2023 report, 2.0× the same report last year.
Same report last year: 19.5M; its normal report is 21.7M.
See the evidence
This period
39.7M (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
21.7M
Typical spread (median absolute deviation)
2.3M
How far from its usual level
+5.3
Same report last year
19.5M
History used
2,191 days
the 29 Dec 2023 report24 earlier reportsnormal: 21.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 44.1M shares sold short in the 15 Dec 2023 report, 2.3× the same report last year.
Same report last year: 19.0M; its normal report is 20.9M.
See the evidence
This period
44.1M (the 15 Dec 2023 report)
Normal report (median of 24 earlier)
20.9M
Typical spread (median absolute deviation)
1.6M
How far from its usual level
+9.6
Same report last year
19.0M
History used
2,177 days
the 15 Dec 2023 report24 earlier reportsnormal: 20.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 43.1M shares sold short in the 30 Nov 2023 report, 2.2× the same report last year.
Same report last year: 19.9M; its normal report is 20.6M.
See the evidence
This period
43.1M (the 30 Nov 2023 report)
Normal report (median of 24 earlier)
20.6M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+10.9
Same report last year
19.9M
History used
2,162 days
the 30 Nov 2023 report24 earlier reportsnormal: 20.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 45.4M shares sold short in the 15 Nov 2023 report, 2.0× the same report last year.
Same report last year: 22.5M; its normal report is 20.6M.
See the evidence
This period
45.4M (the 15 Nov 2023 report)
Normal report (median of 24 earlier)
20.6M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+12.0
Same report last year
22.5M
History used
2,147 days
the 15 Nov 2023 report24 earlier reportsnormal: 20.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 34.2M shares sold short in the 31 Oct 2023 report, 1.8× the same report last year.
Same report last year: 19.0M; its normal report is 20.5M.
See the evidence
This period
34.2M (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
20.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+6.7
Same report last year
19.0M
History used
2,132 days
the 31 Oct 2023 report24 earlier reportsnormal: 20.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 30.4M shares sold short in the 13 Oct 2023 report, 1.6× the same report last year.
Same report last year: 18.6M; its normal report is 20.2M.
See the evidence
This period
30.4M (the 13 Oct 2023 report)
Normal report (median of 24 earlier)
20.2M
Typical spread (median absolute deviation)
980K
How far from its usual level
+5.1
Same report last year
18.6M
History used
2,114 days
the 13 Oct 2023 report24 earlier reportsnormal: 20.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
lobbying on a new issue, while it had 44.1M shares sold short in the 15 Dec 2023 report, 2.3× the same report last year. Two unrelated kinds of activity within 133 days.
See the evidence (11 changes)
Short interest and volume: Short interest spike became public on 13 Sep 2023
Agenus had 29.3M shares sold short in the 31 Aug 2023 report, 1.7× the same report last year.
This period
29.3M (the 31 Aug 2023 report)
Normal report (median of 24 earlier)
19.7M
Typical spread (median absolute deviation)
801K
How far from its usual level
+4.9
Same report last year
16.9M
History used
2,071 days
the 31 Aug 2023 report24 earlier reportsnormal: 19.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 27 Sep 2023
Agenus had 29.3M shares sold short in the 15 Sep 2023 report, 1.8× the same report last year.
This period
29.3M (the 15 Sep 2023 report)
Normal report (median of 24 earlier)
20.0M
Typical spread (median absolute deviation)
878K
How far from its usual level
+4.6
Same report last year
16.1M
History used
2,086 days
the 15 Sep 2023 report24 earlier reportsnormal: 20.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Lobbying: Lobbying on a new issue became public on 16 Oct 2023
Agenus lobbying on a new issue.
New
['HCR']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12617734
Short interest and volume: Short interest spike became public on 12 Oct 2023
Agenus had 28.1M shares sold short in the 29 Sep 2023 report, 1.7× the same report last year.
This period
28.1M (the 29 Sep 2023 report)
Normal report (median of 24 earlier)
20.0M
Typical spread (median absolute deviation)
929K
How far from its usual level
+4.0
Same report last year
16.9M
History used
2,100 days
the 29 Sep 2023 report24 earlier reportsnormal: 20.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Oct 2023
Agenus had 30.4M shares sold short in the 13 Oct 2023 report, 1.6× the same report last year.
This period
30.4M (the 13 Oct 2023 report)
Normal report (median of 24 earlier)
20.2M
Typical spread (median absolute deviation)
980K
How far from its usual level
+5.1
Same report last year
18.6M
History used
2,114 days
the 13 Oct 2023 report24 earlier reportsnormal: 20.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Nov 2023
Agenus had 34.2M shares sold short in the 31 Oct 2023 report, 1.8× the same report last year.
This period
34.2M (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
20.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+6.7
Same report last year
19.0M
History used
2,132 days
the 31 Oct 2023 report24 earlier reportsnormal: 20.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 28 Nov 2023
Agenus had 45.4M shares sold short in the 15 Nov 2023 report, 2.0× the same report last year.
This period
45.4M (the 15 Nov 2023 report)
Normal report (median of 24 earlier)
20.6M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+12.0
Same report last year
22.5M
History used
2,147 days
the 15 Nov 2023 report24 earlier reportsnormal: 20.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Dec 2023
Agenus had 43.1M shares sold short in the 30 Nov 2023 report, 2.2× the same report last year.
This period
43.1M (the 30 Nov 2023 report)
Normal report (median of 24 earlier)
20.6M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+10.9
Same report last year
19.9M
History used
2,162 days
the 30 Nov 2023 report24 earlier reportsnormal: 20.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 28 Dec 2023
Agenus had 44.1M shares sold short in the 15 Dec 2023 report, 2.3× the same report last year.
This period
44.1M (the 15 Dec 2023 report)
Normal report (median of 24 earlier)
20.9M
Typical spread (median absolute deviation)
1.6M
How far from its usual level
+9.6
Same report last year
19.0M
History used
2,177 days
the 15 Dec 2023 report24 earlier reportsnormal: 20.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Jan 2024
Agenus had 39.7M shares sold short in the 29 Dec 2023 report, 2.0× the same report last year.
This period
39.7M (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
21.7M
Typical spread (median absolute deviation)
2.3M
How far from its usual level
+5.3
Same report last year
19.5M
History used
2,191 days
the 29 Dec 2023 report24 earlier reportsnormal: 21.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Jan 2024
Agenus had 41.9M shares sold short in the 12 Jan 2024 report, 2.1× the same report last year.
This period
41.9M (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
23.0M
Typical spread (median absolute deviation)
3.6M
How far from its usual level
+3.5
Same report last year
20.3M
History used
2,205 days
the 12 Jan 2024 report24 earlier reportsnormal: 23.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
16 Oct 2023Lobbying change
lobbying on a new issue.
See the evidence
New
['HCR']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12617734
12 Oct 2023Short interest and volume change
had 28.1M shares sold short in the 29 Sep 2023 report, 1.7× the same report last year.
Same report last year: 16.9M; its normal report is 20.0M.
See the evidence
This period
28.1M (the 29 Sep 2023 report)
Normal report (median of 24 earlier)
20.0M
Typical spread (median absolute deviation)
929K
How far from its usual level
+4.0
Same report last year
16.9M
History used
2,100 days
the 29 Sep 2023 report24 earlier reportsnormal: 20.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 29.3M shares sold short in the 15 Sep 2023 report, 1.8× the same report last year.
Same report last year: 16.1M; its normal report is 20.0M.
See the evidence
This period
29.3M (the 15 Sep 2023 report)
Normal report (median of 24 earlier)
20.0M
Typical spread (median absolute deviation)
878K
How far from its usual level
+4.6
Same report last year
16.1M
History used
2,086 days
the 15 Sep 2023 report24 earlier reportsnormal: 20.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 29.3M shares sold short in the 31 Aug 2023 report, 1.7× the same report last year.
Same report last year: 16.9M; its normal report is 19.7M.
See the evidence
This period
29.3M (the 31 Aug 2023 report)
Normal report (median of 24 earlier)
19.7M
Typical spread (median absolute deviation)
801K
How far from its usual level
+4.9
Same report last year
16.9M
History used
2,071 days
the 31 Aug 2023 report24 earlier reportsnormal: 19.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
spent $18.5M on capital projects in the quarter ended 30 Jun 2022, 8.1× the same quarter last year.
Same quarter last year: $2.3M; its normal quarter is $994K.
See the evidence
This period
$18.5M (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
$994K
Typical spread (median absolute deviation)
$574K
How far from its usual level
+17.5
Same quarter last year
$2.3M
History used
4,291 days
the quarter ended 30 Jun 20228 earlier quartersnormal: $994K
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
Showing the newest 40 of 97 entries; narrow the window or the kind of data to see older ones.
Not listed: 142 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001098972
Ticker
AGEN
Domain
agenusbio.com
Employer name
Agenus Inc. (1 unverified)
Hq location
MA|LEXINGTON|02421 (1 unverified)
Lobbying client
agenus
Name
agen-ex21_1.htm, Agenus Holdings 2024, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Agenus Inc, Agenus Inc., Agenus Royalty Fund, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Agenus Inc and 6 more
Uei
L676WHGKTJN3
Wikidata
Q4692116
Wikipedia
Agenus
DOL H-1B labor condition applications and PERM certifications93 data points16 Dec 2019 to 10 Nov 2025
Federal lobbying disclosures (LDA)4 records, 29 data points6 Sep 2017 to 31 Mar 2024
SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)175 records4 Jan 2016 to 5 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1051 data points31 Dec 2008 to 3 Nov 2026
SEC Form 4 insider transactions20 records, 52 data points8 Mar 2016 to 15 Feb 2024
FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards12 data points22 Sep 2016 to 9 May 2025
Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026